New drug approved to treat HIV.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D017277:Drug Approval; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000009:adverse effects*; D019888:Nelfinavir; D013451:Sulfonic Acids / Q000008:administration & dosage* / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D013451:Sulfonic Acids; D019888:Nelfinavir